Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01093 CSPC PHARMA
RTNominal unchange8.150 0.000 (0.000%)
Others

23/09/2021 11:12

CSPC Pharma (01093) signs strategic alliance agreement

[ET Net News Agency, 23 September 2021] CSPC Pharmaceutical Group Limited (01093) said
on 22 September 2021, Shanghai JMT-Bio Technology Co., Ltd. (JMT-Bio), a wholly-owned
subsidiary of the company, has entered into a strategic alliance agreement with Keymed
Bioscience (Chengdu) Co., Ltd. (Chengdu Keymed), a wholly-owned subsidiary of Keymed
Biosciences Inc. (Keymed Bio).
Under the terms of the agreement, JMT-Bio and Chengdu Keymed shall jointly identify,
research, develop and commercialize one or more products for nervous system diseases (the
collaboration products). JMT-Bio will primarily be responsible for clinical development
and commercialization of the collaboration products and Chengdu Keymed will primarily be
responsible for pre-clinical research and development of the collaboration products. (RC)

Remark: Real time quote last updated: 08/12/2021 08:37
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.